Cohen & Steers (CNS) Stock: Buy, Sell, or Hold?
CNS - Cohen & Steers Inc.
$73.12
0.01 (0.01%)
▲
5d:
-2.7%
30d:
-5.64%
90d:
-6.94%
HOLD
MODERATE Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 15, 2026
12d
Get Alerted When CNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CNS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$112.44
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$69.82
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNS is currently trading at $73.12, which is considered slightly low relative to its 30-day fair value range of $73.04 to $80.37. The stock's valuation (Forward PE: 18.4) is in line with its historical norms (19.0). Remarkably, the market is currently pricing in an annual earnings decline of 1.1% over the next few years. This pessimistic expectation contrasts with the company's recent 31.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CNS is in a uptrend. The price is currently testing key support at $71.97. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNS is in a uptrend. The price is currently testing key support at $71.97. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$73.04 -
$80.37
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (57/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($76.33)
- NEUTRAL: Bottoming setup forming (57/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$73.04 -
$80.37
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$71.97
Resistance Level
$76.79
Current Trend
Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.37
Wall Street Target
$76.33
(+4.4%)
Revenue Growth (YoY)
12.2%
Earnings Growth (YoY)
31.9%
Profit Margin
28.8%
Valuation Discount vs History
-1.1% cheaper
PE vs Historical
18.4 vs 19.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.1%
(market-implied from PE analysis)
1-Year Target
$72.32
(-1%)
2-Year Target
$71.52
(-2%)
3-Year Target
$70.73
(-3%)
3-Yr Target (if PE normalizes)
(PE: 18→19)
$73.15
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 12.6%)
$116.04
(+59%)
Base:
(SPY PE: 18.4, Growth: 12.6%)
$104.51
(+43%)
Bear:
(PE: 15.6, Growth: 12.6%)
$88.83
(+22%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 22.43 | Current EPS (TTM): $3.26
Bull Case
$98.18
(+34%)
Analyst growth 22.1%, PE expands to 24.7
Base Case
$89.26
(+22%)
Market implied 22.1%, PE stable at 22.4
Bear Case
$49.71
(-32%)
Severe decline -20.0%, PE contracts to 19.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.4 to 19.0
Stabilization Target:
$75.62
(+3.4%)
PE Expansion Potential:
+3.4%
Share & Embed Analysis
Last updated: October 02, 2026 9:41 AM ET
Data refreshes hourly during market hours. Next update: 10:41 AM
Data refreshes hourly during market hours. Next update: 10:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Asset Management Stocks
Top-rated stocks in Asset Management by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KKR
KKR & Co. Inc. |
STRONG BUY
21 analysts |
$129 | 45 HOLD |
|
BLK
BlackRock Inc |
STRONG BUY
17 analysts |
$1323 | 58 HOLD |
|
BX
Blackstone Group Inc |
HOLD
23 analysts |
$144 | 53 HOLD |
|
CG
Carlyle Group Inc |
HOLD
17 analysts |
$58 | 79 BUY |
|
OWL
Blue Owl Capital Inc |
STRONG BUY
15 analysts |
$13 | 51 HOLD |
